clinical trial · NCT03915431
A Study of NCS-01 in Patients With Acute Ischemic Stroke
NC Medial Research Inc·phase2·active not recruiting·n = 16
Ischemic StrokeNCS-01
brief summary
This is an initial Phase1/2 dose-finding, randomized, multi-center study to evaluate the safety and tolerability of NCS-01 in patients with acute ischemic stroke. All patients will be randomized within 48 hours of stroke onset. This study will be conducted in 2 stages.
started
Feb 27, 2020
primary completion
Oct 1, 2027
completion
Oct 1, 2028
last updated
Sep 11, 2025
official title
A Phase 1/2 Randomized Study to Evaluate the Safety and Tolerability of Intracarotid Artery Administration of NCS-01 in Patients With Acute Ischemic Stroke
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol